You are here
Publications
] .
1980. Disturbance of consciousness and hypocalcemia after neomycin irrigation, and reversal by calcium and physostigmine.. Anesthesiology. 53(1):69-71.
.
1980. Human dose-response curves for neuromuscular blocking drugs: a comparison of two methods of construction and analysis.. Anesthesiology. 53(2):161-6.
.
1980. Increased d-tubocurarine requirement following major thermal injury.. Anesthesiology. 52(4):352-5.
.
1980. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine.. Anesth Analg. 59(8):604-9.
.
1980. Stimulus frequency and dose-respone curve to d-tubocurarine in man.. Anesthesiology. 52(1):36-9.
.
1981. Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone.. Anesth Analg. 60(1):12-7.
.
1981. Hydrogen exchange in the formation of dihydroxyacetone phosphate from acyl dihydroxyacetone phosphate in O-alkyl lipid synthesis in Ehrlich ascites tumor cell microsomes.. J Biol Chem. 256(1):291-5.
.
1981. The new neuromuscular blocking drugs are here.. Anesthesiology. 55(1):1-3.
.
1981. Role of histamine in the hypotensive action of d-tubocurarine in humans.. Anesthesiology. 55(1):19-25.
.
1981. Twitch, tetanus and train-of-four as indices of recovery from nondepolarizing neuromuscular blockade.. Anesthesiology. 54(4):294-7.
.
1981. The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind study.. Anesthesiology. 55(3):292-6.
.
1982. Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant.. Anesth Analg. 61(9):723-9.
.
1982. Histamine release by neuromuscular blocking agents in man.. Klin Wochenschr. 60(17):891-5.
.
1982. Histamine release during morphine and fentanyl anesthesia.. Anesthesiology. 56(2):93-6.
.
1982. Pharmacokinetics of d-tubocurarine in patients with thermal injury.. Anesth Analg. 61(3):241-6.
.
1982. Psychology at Cornell after Titchener: Madison Bentley to Robert Macleod, 1928-1948.. J Hist Behav Sci. 18(4):347-69.
.
1983. The clinical pharmacology of BW A444U. A nondepolarizing ester relaxant of intermediate duration.. Anesthesiology. 58(4):333-41.
.
1983. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.. Br J Anaesth. 55 Suppl 1:107S-111S.
.
1983. Histamine-releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine.. Br J Anaesth. 55 Suppl 1:105S-106S.
.
1984. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated neuronal phosphoprotein. II. Comparison of the kinetics of phosphorylation of DARPP-32 and phosphatase inhibitor 1.. J Biol Chem. 259(23):14491-7.
.
1984. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated neuronal phosphoprotein. I. Amino acid sequence around the phosphorylated threonine.. J Biol Chem. 259(23):14486-90.
.
1984. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus.. J Neurosci. 4(1):99-110.
.
1984. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization.. J Neurosci. 4(1):111-24.
.
1984. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1.. Nature. 310(5977):503-5.
.
1984. Mammalian brain phosphoproteins as substrates for calcineurin.. J Biol Chem. 259(13):8080-3.